Airdoc 鹰瞳科技 vs Ubie
A side-by-side look at scores, pricing and features — with RECATOOLS' ASEAN-aware verdict for each.
Airdoc 鹰瞳科技
HK-listed AI retinal screening for eye and chronic-disease risk
Visit
|
Ubie
Japan's AI symptom checker — 20 questions, 3 minutes, no signup
Visit
|
|
|---|---|---|
| RECATOOLS Score | 6.8 / 10 | 7.8 / 10 |
| Capability | ||
| Value for money | ||
| Ease of use | ||
| ASEAN readiness | ||
| API quality | ||
| Pricing | Enterprise | Freemium |
| Free tier | — | Core symptom checker free, no registration required |
| Paid from | — | Medical Navigator (AI問診) B2B is quote-based, not publicly disclosed |
| Has API | ✗ | ✗ |
| Open source | ✗ | ✗ |
| Free to use | ✗ | ✓ |
| Users | — | 10M+ monthly users globally; 1,800+ medical institutions in Japan (2025) |
| Founded | — | 2017 |
| Maker | — | Ubie, Inc. |
| Verdict | A single retinal photo, read by Airdoc's model in about three minutes, is enough to flag diabetic retinopathy and eight other chronic-disease risk indicators alongside 35 named eye conditions — a genuinely differentiated... |
Ubie clears a bar most AI symptom checkers don't bother with: published, peer-reviewed accuracy data. A 2024 medRxiv vignette study put its top-10 diagnostic hit rate at 71.6%, close to the 72.9% median for physicians on... |
| Full review → | Full review → |
← Back to AI Directory
Comparisons cover up to 4 tools. Scores are RECATOOLS editorial assessments; verify current pricing on each vendor's site.